innoscripta

innoscripta EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of innoscripta (1INN.MU) as of Nov 19, 2026 is 10.16. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 17.28 — a change of -41.20% (lower).

EV/EBIT

10.16

YoY

-41.20%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of innoscripta is 2025 10.16 . EV/EBIT (Enterprise Value to EBIT) of innoscripta was 2024 17.28 . It decreases by -41.20% lower compared to the previous year.

The innoscripta EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2022
70.49 EUR
Jan 1, 2023
41.44 EUR
Jan 1, 2024
17.28 EUR
Jan 1, 2025
10.16 EUR
Jan 1, 2026 (e)
5.46 EUR
The innoscripta EV/EBIT history
YEAREV/EBITYoY
est5.46-46.26%
10.16-41.20%
17.28-58.30%
41.44-41.21%
70.49—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

innoscripta Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides innoscripta's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates innoscripta's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots innoscripta's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if innoscripta grows earnings faster than its peers.

innoscripta Stock analysis

What does innoscripta do? innoscripta SE generates revenue through its SaaS platform providing cloud-based compliance software for R&D tax credits and project management. The company serves funding consulting and support companies across various industries, offering tools for project management, time recording, employee management, and data interfaces to third-party systems. Its platform helps clients identify, validate, and manage R&D projects while ensuring compliant documentation for tax credits. The firm's SaaS solution is designed to streamline R&D process management for clients in diverse sectors. innoscripta SE's primary customers are funding consulting and support companies that assist businesses in securing R&D funding. These clients use the company's software to manage documentation, track project progress, and interface with external systems. The platform's focus on compliance and tax credit validation makes it essential for clients navigating complex regulatory environments. The company's revenue model relies on subscription-based access to its integrated software suite. The business model centers on delivering a comprehensive SaaS solution that integrates multiple functions into one platform. By combining project management, time tracking, employee management, and third-party data integration, innoscripta SE provides a unified system for R&D project oversight. This approach reduces the need for multiple software tools, appealing to clients seeking efficiency and compliance in their R&D operations. innoscripta is one of the most popular companies on Eulerpool.

Frequently Asked Questions about innoscripta stock

EV/EBIT (Enterprise Value to EBIT) of innoscripta is 10.16 in 2025.

EV/EBIT (Enterprise Value to EBIT) of innoscripta changed from 17.28 to 10.16, representing a -41.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) innoscripta since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s innoscripta with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — innoscripta

All Key Metrics — innoscripta